| Primary |
| Prophylaxis |
28.5% |
| Breast Cancer Recurrent |
16.4% |
| Breast Cancer |
10.2% |
| Metastases To Bone |
7.0% |
| Metastases To Liver |
5.8% |
| Product Used For Unknown Indication |
5.5% |
| Breast Cancer Metastatic |
4.4% |
| Metastases To Lung |
4.1% |
| Metastases To Lymph Nodes |
3.0% |
| Constipation |
2.5% |
| Pain |
2.1% |
| Cancer Pain |
1.7% |
| Metastatic Breast Cancer |
1.4% |
| Hypertension |
1.3% |
| Nausea |
1.3% |
| Cough |
1.2% |
| Gastritis |
1.0% |
| Metastases To Skin |
1.0% |
| Premedication |
0.8% |
| Prophylaxis Of Nausea And Vomiting |
0.8% |
|
| Interstitial Lung Disease |
13.5% |
| Neutropenia |
11.8% |
| Pneumonia |
8.8% |
| Febrile Neutropenia |
7.8% |
| Leukopenia |
6.4% |
| Pleural Effusion |
6.1% |
| Stomatitis |
6.1% |
| Sepsis |
4.4% |
| Pyrexia |
4.1% |
| Thrombocytopenia |
3.7% |
| Malignant Neoplasm Progression |
3.0% |
| Neoplasm Malignant |
3.0% |
| Vomiting |
3.0% |
| Fatigue |
2.7% |
| Malaise |
2.7% |
| Neuropathy Peripheral |
2.7% |
| Pulmonary Embolism |
2.7% |
| Renal Failure Acute |
2.7% |
| Dyspnoea |
2.4% |
| Headache |
2.4% |
|
| Secondary |
| Prophylaxis |
37.8% |
| Breast Cancer Recurrent |
14.7% |
| Metastases To Bone |
11.0% |
| Metastases To Liver |
8.3% |
| Metastases To Lung |
6.2% |
| Metastases To Lymph Nodes |
4.9% |
| Product Used For Unknown Indication |
3.1% |
| Breast Cancer |
2.6% |
| Cancer Pain |
2.1% |
| Constipation |
2.0% |
| Metastases To Skin |
1.6% |
| Metastases To Breast |
1.3% |
| Pleural Disorder |
0.7% |
| Breast Cancer Metastatic |
0.6% |
| Pain |
0.6% |
| Cough |
0.5% |
| Pruritus |
0.5% |
| Oedema |
0.5% |
| Faecaloma |
0.5% |
| Nausea |
0.5% |
|
| Neutropenia |
12.5% |
| Leukopenia |
10.4% |
| Pneumonia |
10.2% |
| Febrile Neutropenia |
8.4% |
| Thrombocytopenia |
7.3% |
| Stomatitis |
5.0% |
| Malignant Neoplasm Progression |
4.7% |
| Interstitial Lung Disease |
4.4% |
| Pyrexia |
4.2% |
| Lymphopenia |
3.9% |
| Neoplasm Malignant |
3.9% |
| Tumour Lysis Syndrome |
3.7% |
| Hepatic Function Abnormal |
3.4% |
| Pleural Effusion |
3.1% |
| Pulmonary Haemorrhage |
3.1% |
| Sepsis |
2.9% |
| C-reactive Protein Increased |
2.3% |
| Headache |
2.3% |
| Lung Infection |
2.1% |
| Supraventricular Tachycardia |
2.1% |
|
| Concomitant |
| Breast Cancer |
17.6% |
| Product Used For Unknown Indication |
17.6% |
| Metastases To Bone |
14.8% |
| Breast Cancer Recurrent |
13.9% |
| Breast Cancer Metastatic |
11.1% |
| Nausea |
3.7% |
| Pain |
2.8% |
| Cancer Pain |
1.9% |
| Constipation |
1.9% |
| Cough |
1.9% |
| Disease Progression |
1.9% |
| Her-2 Positive Breast Cancer |
1.9% |
| Hypertension |
1.9% |
| Osteoporosis |
1.9% |
| Autonomic Neuropathy |
0.9% |
| Breast Cancer Female |
0.9% |
| Chemotherapy |
0.9% |
| Chronic Myeloid Leukaemia |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Clostridial Infection |
0.9% |
|
| Pain In Extremity |
10.3% |
| Cardiotoxicity |
6.9% |
| Febrile Neutropenia |
6.9% |
| Osteonecrosis Of Jaw |
6.9% |
| Pain In Jaw |
6.9% |
| Subileus |
6.9% |
| Swelling |
6.9% |
| White Blood Cell Count Decreased |
6.9% |
| Asthenia |
3.4% |
| Bone Pain |
3.4% |
| Breast Cancer Metastatic |
3.4% |
| Death |
3.4% |
| Impaired Healing |
3.4% |
| Injection Site Pain |
3.4% |
| Liver Disorder |
3.4% |
| Lung Infection |
3.4% |
| Pyrexia |
3.4% |
| Tetany |
3.4% |
| Toothache |
3.4% |
| Toxic Skin Eruption |
3.4% |
|
